Back to DODGE & COX DODGE & COX

REGNREGN
Showing 8 of 19 quarters

Position history for DODGE & COXDODGE & COX's holdings in REGENERON PHARMACEUTICALS

DODGE & COX holds 4.9M shares of REGN (REGENERON PHARMACEUTICALS), worth $3B as of 2026-Q2. The position was increased (+9.3% shares). REGN represents 1.6% of DODGE & COX's portfolio.

Current Value

$3B

Current Shares

4.9M

Total Value Change

+$607M

Total Shares Change

+2.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.9M
+9.3%
$3B1.6%$622.81
55
2026-Q1
Decreased
4.5M
-3.0%
$3.4B1.9%$770.59
0
2025-Q4
Increased
4.6M
+1.0%
$3.5B1.9%$768.90
51
2025-Q3
Increased
4.6M
+18.9%
$2.6B1.4%$559.40
59
2025-Q2
Increased
3.8M
+64.6%
$2B1.1%$521.53
73
2025-Q1
Increased
2.3M
+0.1%
$1.5B0.8%$629.11
45
2024-Q4
Increased
2.3M
+0.4%
$1.7B1.0%$705.67
45
2024-Q3
Decreased
2.3M
-0.2%
$2.4B1.4%$1,041.41
0

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used